Annette Altmann

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: June 03, 2024

18F-labeled tracers targeting fibroblast activation protein.

18F-labeled tracers targeting fibroblast activation protein.

Journal: EJNMMI radiopharmacy and chemistry
Published: June 07, 2021

Ligand engineering for theranostic applications.

Ligand engineering for theranostic applications.

Journal: Current opinion in chemical biology
Published: December 01, 2020

The Latest Developments in Imaging of Fibroblast Activation Protein.

The Latest Developments in Imaging of Fibroblast Activation Protein.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 02, 2020

FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 13, 2020

Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy.

Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: November 14, 2019

Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery.

Improving antibody-based therapies by chemical engineering of antibodies with multimeric cell-penetrating peptides for elevated intracellular delivery.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 18, 2019

Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.

Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.

Journal: Nuklearmedizin. Nuclear medicine
Published: May 11, 2019

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 05, 2019

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 19, 2019

Targeting of activated fibroblasts for imaging and therapy.

Targeting of activated fibroblasts for imaging and therapy.

Journal: EJNMMI radiopharmacy and chemistry
Published: February 05, 2019

PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide.

PET/CT Imaging of NSCLC with a αvβ6 Integrin-Targeting Peptide.

Journal: Molecular imaging and biology
Published: January 24, 2019
Showing 1-12 of 30

Last Updated: 09/26/2026